The largest database of trusted experimental protocols

7 protocols using recombinant human tnf α

1

Nutlin3a Modulation of TNF-α-Induced Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells seeded in 384-well plates were infected with CTL2 as described in the
infectious progeny assay. Cells were treated with Nutlin3a at the indicated
concentrations from 12 h p.i. Ten hours post Nutlin3a treatment, medium was
exchanged and recombinant human TNF-α (BD Pharmingen, 554618) was added at the
indicated concentrations with
10 μg ml−1cycloheximide (Sigma,
065K12261) together with Nutlin3a and incubated for 5 h until fixation and
immunolabelling.
+ Open protocol
+ Expand
2

Culturing and Treating HUVECs under Hypoxia and TNF-α

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human Umbilical Vein Endothelial Cells (HUVECs) were cultured in a humidified atmosphere containing 5% CO2 at 37°C in Endothelial Growth Medium-2 (EGM2, Lonza, Switzerland). For hypoxia induction, cells were incubated in a hypoxia chamber with a mixture of 1% O2, 5% CO2, and 94% N2. For TNF-α stimulation, 10 ng/ml of recombinant human TNF-α (BD Biosciences, USA) was added into the HUVECs medium. Piperlongumine (Sigma-Aldrich, USA) was dissolved in dimethylsulfoxide (DMSO, Sigma-Aldrich, USA) before usage. The culture medium was replaced every 1-2 days, and cells at 85-90% confluence were passaged at a ratio of 1:2 confluence.
+ Open protocol
+ Expand
3

Measuring Serum TNF-α and Receptors in RMI

Check if the same lab product or an alternative is used in the 5 most similar protocols
The peripheral venous blood was collected at 8:00 AM and at 9:00 AM in the morning after an overnight fast (12 h) from all patients with RMI, and the serum samples were frozen and stored at -80°C until examination. According to manufacturer's specifications, plasma TNF levels were measured by ELISA using purified and biotinylated antihuman TNF monoclonal antibodies and recombinant human TNF (BD Biosciences Phar Mingen, San Diego, CA, USA). All samples were processed by ELISA plate reader (Bio-Rad, CA, USA) [28 (link)]. Serum was separated from blood samples and frozen at -80°C, and the levels of sTNFR-1 and sTNFR-2 were measured by ELISA kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's specifications. The concentration of TNF-α, sTNFR-1, and sTNFR-2 were expressed as ng/L [28 (link)].
+ Open protocol
+ Expand
4

ELISA Protocol for Cytokine Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISA was performed according to the manufacturer’s protocol. Immuno™ Maxisorp™ plates (NUNC-Thermo Fisher Scientific, 442404) were coated overnight at 4°C with anti-human IL-6 (eBioscience™), anti-human TNF-α antibodies (BD Pharmingen™) or anti-human IL-1β antibodies (R&D Systems). Plates were washed and blocked with phosphate buffered saline (PBS) containing 1% bovine serum albumin (BSA) for 2h at 37°C. Plates were washed and incubated with supernatant or standard dilutions of recombinant human TNF-α (BD Pharmingen™), IL-6 (Thermo Fisher Scientific) or IL-1β (R&D Systems). Biotin Mouse anti-Human TNF-α detection antibody (BD Pharmingen™), Biotin Mouse anti-human IL-6 detection antibody (eBioscience™) or Biotin mouse anti-Human IL-1β detection antibody (R&D Systems) was added as secondary antibody. RPMI medium was used as a negative control. Serum from LPS-activated WB was used as a positive control. Plates were washed and incubated with 3,3′,5,5′-tetramethylbenzidine (TMB) after which the reaction was stopped with sulfuric acid (0.8 M H2SO4). The absorbance was measured at OD450 nm on a SpectraMax® iD3 Reader with SoftMax Pro 7 software. All conditions were performed in duplicate.
+ Open protocol
+ Expand
5

Inducing Necroptosis in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the induction of necroptosis, MEFs were pre‐treated with 10 μM BV6 (Smac mimetic) and 20 μM zVAD‐fmk (hereafter zVAD) for 1 h. Recombinant mouse TNFα (50 ng/ml, R&D systems) was added for 6 h unless stated otherwise. HT29 cells were pre‐treated with 10 μM BV6 and/or 20 μM zVAD for 1 h. Recombinant human TNFα (30 ng/ml) was added for 4 h. Cell‐death was evaluated using Annexin V/7‐AAD (BD Biosciences) coupled with flow‐cytometry.
+ Open protocol
+ Expand
6

Cell Culture Reagents and Experimental Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hyclone (Logan, UT, USA) provided Dulbecco’s modified Eagle’s medium (DMEM), RPMI 1640 medium, and fetal bovine serum (FBS). We obtained EBM-2 medium and EGM-2 Endothelial SingleQuots Kit from Lonza (Basel, Switzerland) and 2-mercaptoethanol from Gibco (Grand Island, NY, USA). We purchased recombinant human TNF-α from BD Pharmingen (San Diego, CA, USA) and recombinant mouse TNF-α from NKMAX (Seongnam-si, Gyeonggi-do, Korea). Sigma-Aldrich (St. Louis, MO, USA) provided 2′,7′-dichlorofluorescein diacetate (DCFH-DA) and analytical-grade reference standards (methyl gallate, catechin hydrate, paeoniflorin, benzoic acid, and paeonol). We used horseradish peroxidase (HRP)-conjugated pierce goat antirabbit IgG (H+L), pierce goat antimouse IgG (H+L), and Alexa Fluor 488 and 594 goat antirabbit IgG (H+L) for the secondary antibodies, purchasing these from Thermo Fisher Scientific Inc. (Eugene, OR, USA). The PLE reference standards, oxypaeoflorin, benzoyl paeoniflorin, and albiflorin, were purchased from Ensol Biosciences Inc. (Daejeon, Korea), Biosynth Carbosynth (San Diego, CA, USA), and FUJIFILM Wako Pure Chemical Corporation (Richmond, VA, USA).
+ Open protocol
+ Expand
7

Peptide-mediated Cytokine Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells seeded in 24-well plates were infected with CTL2 as described for infectious progeny assay. Cells were treated with peptide at the indicated concentrations from 24 h p.i., recombinant human TNFα (BD Pharmingen, 554618) was added at the indicated concentrations together with 10 μg/ml cycloheximide (Sigma, 065K12261) and incubated for 5 h until harvesting, immunoblotting and immunofluorescence.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!